(RYTM) Rhythm Pharmaceuticals - Performance 49.6% in 12m
Compare RYTM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
66.20%
#7 in Group
Rel. Strength
90.69%
#746 in Universe
Total Return 12m
49.60%
#31 in Group
Total Return 5y
203.45%
#9 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.17%
19th Percentile in Group
12m Total Return: RYTM (49.6%) vs XBI (-6.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: RYTM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RYTM
| Total Return (including Dividends) | RYTM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.39% | -10.94% | -6.73% |
| 3 Months | 2.34% | -14.92% | -11.93% |
| 12 Months | 49.60% | -6.46% | 7.24% |
| 5 Years | 203.45% | -19.21% | 100.61% |
| Trend Score (consistency of price movement) | RYTM | XBI | S&P 500 |
| 1 Month | 76.8% | -52.8% | -63.5% |
| 3 Months | -6.80% | -92.8% | -90.3% |
| 12 Months | 80.1% | -32.4% | 60.6% |
| 5 Years | 61.7% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #21 | 25.1% | 19.4% |
| 3 Month | #29 | 20.3% | 16.2% |
| 12 Month | #30 | 59.9% | 39.5% |
| 5 Years | #10 | 276% | 51.3% |
FAQs
Does RYTM Rhythm Pharmaceuticals outperforms the market?
Yes,
over the last 12 months RYTM made 49.60%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months RYTM made 2.34%, while XBI made -14.92%.
Over the last 3 months RYTM made 2.34%, while XBI made -14.92%.
Performance Comparison RYTM vs Indeces and Sectors
RYTM vs. Indices RYTM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.31% | 18.1% | 28.8% | 42.4% |
| US NASDAQ 100 | QQQ | -4.79% | 18.8% | 28.7% | 42.0% |
| US Dow Jones Industrial 30 | DIA | -2.28% | 18.3% | 28.2% | 45.1% |
| German DAX 40 | DAX | -5.53% | 15.3% | 8.94% | 29.3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.74% | 14.8% | 27.7% | 40.4% |
| Hongkong Hang Seng | HSI | -6.98% | 15.1% | 24.3% | 32.8% |
| India NIFTY 50 | INDA | -6.46% | 9.36% | 25.5% | 46.6% |
| Brasil Bovespa | EWZ | -8.58% | 10.9% | 23.8% | 58.3% |
RYTM vs. Sectors RYTM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.02% | 18.2% | 19.7% | 34.5% |
| Consumer Discretionary | XLY | -5.75% | 18.2% | 23.5% | 38.3% |
| Consumer Staples | XLP | -4.46% | 8.41% | 20.9% | 38.3% |
| Energy | XLE | -4.38% | 23.9% | 30.1% | 62.3% |
| Financial | XLF | -5.01% | 16.2% | 20.0% | 31.8% |
| Health Care | XLV | -2.04% | 19.2% | 31.1% | 52.0% |
| Industrial | XLI | -3.71% | 17.4% | 29.0% | 45.5% |
| Materials | XLB | -4.05% | 17.2% | 36.1% | 55.5% |
| Real Estate | XLRE | -4.08% | 14.6% | 29.2% | 34.9% |
| Technology | XLK | -4.58% | 20.4% | 35.1% | 48.4% |
| Utilities | XLU | -4.20% | 11.2% | 25.2% | 27.9% |
| Aerospace & Defense | XAR | -2.86% | 14.6% | 19.5% | 27.7% |
| Biotech | XBI | -7.73% | 22.3% | 40.2% | 56.1% |
| Homebuilder | XHB | -5.84% | 19.5% | 43.6% | 60.1% |
| Retail | XRT | -6.18% | 16.8% | 32.3% | 55.9% |